Delivery Order SPE2DB22D3011-SPE2DB25FQ0DC
Award Date
3/31/25
Potential Completion Date
4/1/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,280.53, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lamotrigine ER 300 mg tablets for a period ending on September 19, 2024. This is a firm fixed-price delivery order contract, which is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lamotrigine ER 200 mg Tablets in quantities of 30. The $3,349.80 contract is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of August 18, 2022 and was awarded on August 17, 2022. The contract is not designated with a set-aside requirement, indicating open competition....
This is a $1,982.65 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of lamotrigine extended-release 300 mg tablets to support federal healthcare programs. It has an ultimate completion date of March 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,843.10, is for the delivery of Lamotrigine ER 300 mg tablets to support military healthcare programs. The contract has an ultimate completion date of July 29, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Lamotrigine ER 25 mg tablets. The contract has a ceiling value of $4,212.78 and a period of performance through February 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of Lamotrigine ER 200 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,480.96 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 22, 2022 with a completion date of March 23, 2022. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,596.03, is for the delivery of Lamotrigine ER 300 mg tablets, a medication used to treat seizures and certain types of mental health conditions. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,893.38 firm-fixed-price delivery order is for the supply of 4565353577 - Lamotrigine Extended-Release 300 mg Tablets in 30-count packages. The award has an ultimate completion date of August 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by DLA and other federal agencies...
This federal contract award, valued at $1,265.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of LAMOTRIGINE ER 100 MG TABLET 30S, a generic medication, with a performance period extending through March 24, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Lamotrigine ER 300 mg tablets, a medication used to treat conditions such as epilepsy and bipolar disorder. The contract has a ceiling value of $6,467.68 and is set to run until January 30, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...